Galectin-9 inhibited the growth of leukemia and myeloma cancer cells through activating transcription factor-ATF-Noxa, JNK, P38 mitogen-activated protein kinase (MAPK) and caspase-3 pathways (149, 150). This evidence concerns the gene LGALS9 and leukemia.